Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.1 (
asparaginase
)
2,695
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acetic anhydride, dextran and monomethoxypolyethylene glycol and different modification methods were used for modification of
L-asparaginase
to maintain enzyme activity and completely remove its antigenicity. The results showed that the macromolecular modifiers PEG and dextran were better than the small molecular modifier acetic anhydride. For maintenance of enzyme activity and removal of antigenicity modification in the presence of substrate was better than absence of substrate and activated PEG2 was better than activated
PEG1
. When PEG2-
L-asparaginase
was modified in the presence of substrate, its antigenicity was completely removed, while more than 30% of native enzyme activity were still retained.
...
PMID:[Effect of several factors on enzymic activity and antigenicity in chemical modification of L-asparaginase]. 171 46